insights_auto
Why is ORX down 3,38%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
4,72 SEK
arrow_downward
-3,38%(-0,16) 1D
28-окт., 17:29:46 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
4,93 SEK
High
5,01 SEK
Low
4,72 SEK
Mkt. cap
165,62 млн
Avg. vol.
126,44 миң
Volume
57,28 миң
P/E ratio
0,20
52-wk high
36,00 SEK
52-wk low
4,72 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
4,93 SEK
High
5,01 SEK
Low
4,72 SEK
Mkt. cap
165,62 млн
Avg. vol.
126,44 миң
Volume
57,28 миң
P/E ratio
0,20
52-wk high
36,00 SEK
52-wk low
4,72 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Reuters
·
12 мүнөт мурун
Asian shares fall as Alphabet earnings miss drags Wall St futures lower
Traders Union
·
1 саат мурун
Potential for Nasdaq to reach 33,000 raised, Jason Pizzino notes
Investor's Business Daily
·
2 саат мурун
Tech Futures Fall On Google, These Huge Losers
Seeking Alpha
·
6 саат мурун
3 things to look out for on Thursday (SP500:)
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB